CR8480A - Formulaciones veterinarias que contienen producto no animal - Google Patents

Formulaciones veterinarias que contienen producto no animal

Info

Publication number
CR8480A
CR8480A CR8480A CR8480A CR8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A
Authority
CR
Costa Rica
Prior art keywords
animal product
formulations containing
animal
containing non
binder
Prior art date
Application number
CR8480A
Other languages
English (en)
Inventor
Cleverly Douglas
Hagenbuch Michelle
Chen Jun
Azad Abul
Muhitch James
Chen Wen-Hsia
Nached Hassan
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of CR8480A publication Critical patent/CR8480A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invencion proporciona una formulacion veterinaria masticable que no contiene productos animales, que comprende: una cantidad efectiva de un agente farmaceuticamente activo que comprende ya sea: a) por lo menos un acido de nodulisporamida o derivado de acido nodulisporico; o b) una combiancion que comprende i) por lo menos un derivado de avermectin o milbemicin; y i) por lo menos un compuesto seleccionado del grupo que consiste de prazicuantel y pirantel; por lo menos un aglutinante; por lo menos un desintegrante; por lo menos un producto no animal que contiene sabor o sabor derivado de una fuente no animal; por lo menos un aglutinante; por lo menos un humectante; por lo menos un solvente de granualcion; y opcionalmente, por lo menos un antioxidante, por lo menos un agente regulador del pH, por lo menos un conservador o por lo menos un colorante.
CR8480A 2003-12-23 2006-06-22 Formulaciones veterinarias que contienen producto no animal CR8480A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/745,784 US20040151759A1 (en) 2002-08-16 2003-12-23 Non-animal product containing veterinary formulations

Publications (1)

Publication Number Publication Date
CR8480A true CR8480A (es) 2007-04-24

Family

ID=34739059

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8480A CR8480A (es) 2003-12-23 2006-06-22 Formulaciones veterinarias que contienen producto no animal

Country Status (9)

Country Link
US (1) US20040151759A1 (es)
EP (1) EP1702056A4 (es)
JP (1) JP2007516285A (es)
KR (1) KR20060126728A (es)
CN (1) CN1972672A (es)
AU (1) AU2004308284A1 (es)
BR (1) BRPI0418098A (es)
CR (1) CR8480A (es)
WO (1) WO2005062782A2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7976884B2 (en) * 2003-08-01 2011-07-12 Nestec Ltd. Edible animal chew toy
NZ529177A (en) * 2003-10-24 2005-12-23 Agres Ltd Administration process for a delivery device that releases the active agent over several days
WO2006036624A2 (en) * 2004-09-24 2006-04-06 The Hartz Mountain Corporation Lipid stabilized formulations
JP4297042B2 (ja) * 2004-11-30 2009-07-15 ブラザー工業株式会社 シート材収納カセット及びそれを備える画像形成装置
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
NZ548931A (en) * 2006-05-15 2008-03-28 Wyeth Corp Stabilised formulation of moxidectin
US9364502B2 (en) * 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2101736A4 (en) * 2006-12-19 2012-09-19 Merial Ltd HOMOGENEOUS PULP AND GEL PREPARATIONS
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
EP2219643B1 (en) * 2007-11-15 2012-05-16 Novartis AG Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
FR2924944A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
AU2008360070B2 (en) * 2008-07-29 2015-04-30 Bomac Research Limited Tablet manufacturing method
AR079409A1 (es) * 2009-09-07 2012-01-25 Mukhopadhyay Debashis Preparaciones antihelminticas granuladas y sistemas de suninistros
JP2013539772A (ja) * 2010-10-12 2013-10-28 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 非澱粉を基にしたソフトチュアブル
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
WO2013037650A1 (fr) 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
EP2594258B1 (en) * 2011-11-18 2020-03-18 Veterinärmedizinische Universität Wien Oral gel comprising praziquantel
HUE043949T2 (hu) * 2012-02-06 2019-09-30 Boehringer Ingelheim Animal Health Usa Inc Szisztémásan ható hatóanyagokat tartalmazó, parazitaellenes, szájon át adagolt állatgyógyászati készítmények, eljárások és alkalmazásuk
US9770440B2 (en) * 2012-04-04 2017-09-26 Intervet Inc. Solid oral pharmaceutical compositions for isoxazoline compounds
KR101348687B1 (ko) * 2012-05-03 2014-01-16 남원모 사료첨가용 은나노 조성물
CN105451771B (zh) 2013-03-15 2020-05-19 阿根塔创新有限公司 可咀嚼配制物
CN103993061B (zh) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 一种鱼胶原蛋白的生产方法
CN114891070A (zh) 2015-05-20 2022-08-12 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
US9808010B2 (en) 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
MX2019005628A (es) 2016-11-16 2019-12-18 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidos antihelminticos.
AU2017370975A1 (en) 2016-12-09 2019-05-30 Bayer Animal Health Gmbh Pharmaceutical preparation and method for its manufacture
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
BR112021018631A2 (pt) 2019-03-19 2021-11-23 Boehringer Ingelheim Animal Health Usa Inc Compostos anti-helmínticos de aza-benzotiofeno e aza-benzofurano
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
CN113134008B (zh) * 2020-01-17 2022-08-30 中国农业大学 宠物用伊维菌素吡喹酮咀嚼片及其制备方法
WO2021242581A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds
EP4706683A2 (en) * 2020-09-03 2026-03-11 Elanco Tiergesundheit AG Chewable formulations
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
JP2023554665A (ja) 2020-12-18 2023-12-28 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド ホウ素含有ピラゾール化合物、それらを含む組成物、それらの方法及び使用
EP4507694A1 (en) 2022-04-15 2025-02-19 KRKA, d.d., Novo mesto Soft chewable veterinary dosage form
CN120361008B (zh) * 2025-04-28 2025-12-09 广州白云山宝神动物保健品有限公司 基于米尔贝肟吡喹酮的寄生虫驱除药物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615728A (en) * 1968-10-11 1971-10-26 Us Agriculture Method for imparting hickory smoke color and flavor to dried yeast and other food powders
US3773525A (en) * 1970-08-31 1973-11-20 A Pittet Flavoring with bicyclic dehydropiperazines
ZA741203B (en) * 1973-03-23 1975-01-29 Smithkline Corp Veterinary feed compositions for inhibiting rumen microbial deamination
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5180720A (en) * 1991-05-03 1993-01-19 G. D. Searle & Co. 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
DE69233130T2 (de) * 1991-05-28 2005-06-02 Mcneil-Ppc, Inc. Kaubare zusammensetzung zur arzneimittelfreisetzung
US5477815A (en) * 1992-08-20 1995-12-26 Booda Products, Inc. Dog chew toy
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
US5785382A (en) * 1994-02-16 1998-07-28 Bettacare Limited Infant car seats
US5894029A (en) * 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
CA2190357C (en) * 1994-05-20 2007-04-17 Eugene Marie Jozef Jans Chewable flubendazole tablets for companion animals
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US6221894B1 (en) * 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6126978A (en) * 1996-10-25 2000-10-03 T.F.H. Publications, Inc. Edible dog chew
US6200616B1 (en) * 1996-10-25 2001-03-13 Tfh Publications, Inc. Animal chew
US6093427A (en) * 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
US6086940A (en) * 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US5827565A (en) * 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US6110521A (en) * 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6093441A (en) * 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6159516A (en) * 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
US6274182B1 (en) * 1999-11-19 2001-08-14 Tfh Publications, Inc. Animal chew
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
US6399786B1 (en) * 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
PT1197215E (pt) * 2000-10-10 2006-07-31 Wyeth Corp Composicoes antelminticas
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US6787642B2 (en) * 2001-03-23 2004-09-07 The Regents Of The University Of California Use of insect cell membrane transporters as novel target sites for inspection
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
EP1702056A4 (en) 2012-05-02
BRPI0418098A (pt) 2007-04-17
CN1972672A (zh) 2007-05-30
JP2007516285A (ja) 2007-06-21
US20040151759A1 (en) 2004-08-05
KR20060126728A (ko) 2006-12-08
EP1702056A2 (en) 2006-09-20
WO2005062782A2 (en) 2005-07-14
AU2004308284A1 (en) 2005-07-14
WO2005062782A3 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
DE60020716D1 (de) Filmbildende zusammensetzungen aus pullulan
CY1117477T1 (el) Κτηνιατρικες μορφοποιησεις που δεν περιεχουν ζωϊκο προϊον
WO2009087474A3 (en) Agonists for antimicrobial peptide systems
MX2010005685A (es) Sistemas de solventes para formulaciones de vaciado determinado para combatir parasitos.
HU229493B1 (en) Antiparasitic formulations
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
PA8541401A1 (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
CY1111923T1 (el) Παρασιτοκτονα σκευασματα
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
GB2386066A (en) Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
JP2016175936A5 (es)
WO2003028475A1 (en) Feeds and fertilizers containing pentacyclic triterpenes
ATE286736T1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
AR036357A1 (es) Composicion de gel endoparasiticida, un metodo para su preparacion y el uso de dicha composición para la manufactura de un medicamento.
PE20010359A1 (es) Formulaciones ectoparasiticidas organicas topicas
ECSP034915A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
BRPI0415392A (pt) composição agroquìmica fungicida, processo para a preparação da mesma, uso de polilisina, derivados de polilisina ou uma combinação de polilisina e derivados de polilisina, processo para o combate de fungos fitopatogênicos, semente,e, material
WO2009103901A3 (fr) Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
WO2008077130A3 (en) Homogeneous paste and gel formulations
ZA202007060B (en) Solid formulation of insecticidal mixtures
WO2005023175A3 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
DE60113807D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
JP2019099552A (ja) 難水溶性活性化合物とビニルピロリドンコポリマーとを含む組成物

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)